2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone
Product Type
Impurity Standards
CAT. No.
MRL-E55004
CAS. No.
32384-65-9
Mol. F.
C18H42O6Si4
Mol. Wt.
466.86
Synonyms
NA
Chemical Name
(3R,4S,5R,6R)-3,4,5-Tris((trimethylsilyl)oxy)-6-(((trimethylsilyl)oxy)methyl)tetrahydro-2H-pyran-2-one
Stock Status
2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone with CAS No:32384-65-9 is an impurity standard of Empagliflozin. Empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, is employed for the management of type 2 diabetes mellitus. By inhibiting SGLT2 in the kidneys, empagliflozin enhances the excretion of glucose in urine, leading to a reduction in blood glucose levels. Beyond its glucose-lowering effects, clinical studies have indicated cardiovascular benefits, demonstrating a reduction in cardiovascular events in individuals with type 2 diabetes and established cardiovascular disease. As part of a comprehensive diabetes management plan, empagliflozin is prescribed under the guidance of healthcare professionals, often complementing lifestyle modifications and other medications to optimize overall diabetes care. Buy high quality 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone from from Molsyns Research. Molsyns Research is one of the leading manufacturer and exporter of 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone
Request for Quotation : 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone